Delivery Order SPE2DB25D3504-SPE2DB25FVVZM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,968.78 to AmerisourceBergen Drug Corp for Prednisolone AC 1% eye drops (5ML) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract...
- The Defense Logistics Agency (DLA) awarded a $1,644.55 delivery order contract to AmerisourceBergen Drug Corp for the supply of Prednisolone AC 1% eye drops (10 milliliter units) with an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,587.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Prednisolone AC 1% eye drops in 5 mL quantities. This firm fixed price, non-set-aside contract is scheduled for completion by August 18, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within the pharmaceutical supply chain that supports...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prednisolone AC 1% eye drops (10ml) on August 28, 2025, with a ceiling value of $2,288.22 and an ultimate completion date of August 29, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Prednisolone AC 1% Eye Drops in 10 ml vials. The contract has a firm fixed price of $2,339.00 and a completion date of September 3, 2024. The award was made on August 30, 2024 and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $2,033.34 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of prednisolone acetate 1% eye drops. This delivery order was placed under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the prime contractor. The IDC enables AmerisourceBergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,160,725 units of 1% Prednisolone AC eye drops in 5 mL vials. The $2,653.63 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,442.12 firm fixed-price delivery order is for the supply of PREDNISOLONE AC 1% EYE DROP 10ML, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a $31,631.96 delivery order contract to Amerisourcebergen Drug Corp for the supply of 4565713394 - PREDNISOLONE AC 1% EYE DROP 5ML. The contract has a firm fixed price and an ultimate completion date of September 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies to support DLA's military treatment programs and facilities worldwide. This order is part of a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Troop Support Medical awarded a $85,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5 ml bottles of 1% prednisolone eye drops. The single day contract runs from August 31, 2023 to September 1, 2023, with performance taking place in Conshohocken, Pennsylvania. No additional details were provided about the original solicitation or whether this delivery order is associated with an existing indefinite delivery/indefinite quantity contract...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVZMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,470.63 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Prednisolone AC 1% eye drops in 10ml quantities. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and serves as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems, the Defense Health Agency, and other government customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/14/25 |